David
Santamaría Velilla
University of Bordeaux
Burdeos, FranciaPublications en collaboration avec des chercheurs de University of Bordeaux (20)
2024
-
In vivo vulnerabilities to GPX4 and HDAC inhibitors in drug-persistent versus drug-resistant BRAFV600E lung adenocarcinoma
Cell Reports Medicine, Vol. 5, Núm. 8
2023
-
Reuniting philosophy and science to advance cancer research
Biological Reviews, Vol. 98, Núm. 5, pp. 1668-1686
2022
-
How far we have come targeting BRAF-mutant non-small cell lung cancer (NSCLC)
Cancer Treatment Reviews, Vol. 103
2021
-
Gene expression profiling as a potential tool for precision oncology in non-small cell lung cancer
Cancers, Vol. 13, Núm. 19
-
Targeting Infrequent Driver Alterations in Non-Small Cell Lung Cancer
Trends in Cancer, Vol. 7, Núm. 5, pp. 410-429
2020
-
Inhibition of DDR1 enhances in vivo chemosensitivity in KRAS-mutant lung adenocarcinoma
JCI Insight, Vol. 5, Núm. 15
-
Meeting report – first discoidin domain receptors meeting
Journal of Cell Science
-
Squamous differentiation requires G2/mitosis slippage to avoid apoptosis
Cell Death and Differentiation, Vol. 27, Núm. 8, pp. 2451-2467
2019
-
Myc stimulates cell cycle progression through the activation of Cdk1 and phosphorylation of p27
Scientific Reports, Vol. 9, Núm. 1
2018
-
A putative role for Discoidin Domain Receptor 1 in cancer chemoresistance
Cell Adhesion and Migration, Vol. 12, Núm. 4, pp. 394-397
-
KRAS Dimerization Impacts MEK Inhibitor Sensitivity and Oncogenic Activity of Mutant KRAS
Cell, Vol. 172, Núm. 4, pp. 857-868.e15
-
Molecular determinants of acquired resistance to BRAF inhibition in human lung cancer
Lung Cancer
2017
-
A Braf kinase-inactive mutant induces lung adenocarcinoma
Nature, Vol. 548, Núm. 7666, pp. 239-243
2014
-
Genetic characterization of the role of the Cip/Kip family of proteins as cyclin-dependent kinase inhibitors and assembly factors
Molecular and Cellular Biology, Vol. 34, Núm. 8, pp. 1452-1459
2011
-
C-Raf, but Not B-Raf, Is Essential for Development of K-Ras Oncogene-Driven Non-Small Cell Lung Carcinoma
Cancer Cell, Vol. 19, Núm. 5, pp. 652-663
2010
-
A Synthetic Lethal Interaction between K-Ras Oncogenes and Cdk4 Unveils a Therapeutic Strategy for Non-small Cell Lung Carcinoma
Cancer Cell, Vol. 18, Núm. 1, pp. 63-73
2007
-
Cdk1 is sufficient to drive the mammalian cell cycle
Nature, Vol. 448, Núm. 7155, pp. 811-815
-
Mice thrive without Cdk4 and Cdk2
Molecular Oncology, Vol. 1, Núm. 1, pp. 72-83
2005
-
Cell cycle and cancer: Genetic analysis of the role of cyclin-dependent kinases
Cold Spring Harbor Symposia on Quantitative Biology
2004
-
Mammalian cells cycle without the D-type cyclin-dependent kinases Cdk4 and Cdk6
Cell, Vol. 118, Núm. 4, pp. 493-504